The ITA notifies wrestler Nurlan Aghazade of an apparent anti-doping rule violation

The ITA reports that a sample collected from Nurlan Aghazade on 12 July 2026 during the U20 European Championships has returned an AAF for the prohibited substance meldonium.

Meldonium is listed under class S4.4 Metabolic Modulators of the World Anti-Doping Agency (WADA) Prohibited List. It is prohibited at all times (in- and out-of-competition) and is classified as a non-specified substance. Meldonium may enhance sports performance by improving endurance and recovery through increased oxygen uptake and energy metabolism.

The athlete has been informed of the case and has the right to request the analysis of the B-sample.

If the B-sample analysis is requested and confirms the result of the A-sample, the case will be considered as a confirmed anti-doping rule violation. If the B-sample analysis is not requested, the case will also go ahead as a confirmed anti-doping rule violation. The athlete will have the opportunity to present his explanations for the result.

Further, in accordance with the World Anti-Doping Code and article 7.4.1 of the UWW anti-doping rules, a mandatory provisional suspension has been imposed on the athlete. The athlete has the right to challenge the provisional suspension and ask for its lifting.

Pursuant to UWW’s delegation of its anti-doping programme to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments made.